Pharmacogenetics of Glucose-Lowering Drug Treatment: A Systematic Review

ISSN： 1177-1062

Source： Molecular Diagnosis & Therapy, Vol.11, Iss.5, 2007-01, pp. : 291-302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and effectiveness of non‐insulin glucose‐lowering agents in the treatment of people with type 2 diabetes who observe Ramadan: a systematic review and meta‐analysis

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 7, 2015-07 ,pp. : 639-648

John Wiley & Sons Inc

Access to resources Recommend Favorite

Glucose‐Lowering Effect of Sevelamer Hydrochloride in Hemodialysis Patients

THERAPEUTIC APHERESIS AND DIALYSIS, Vol. 19, Iss. 4, 2015-08 ,pp. : 412-413

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early glycaemic control among patients with type 2 diabetes and initial glucose‐lowering treatment: a 13‐year population‐based cohort study

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 8, 2015-08 ,pp. : 771-780

John Wiley & Sons Inc

Access to resources Recommend Favorite

Distinct glucose‐lowering properties in good responders treated with sitagliptin and alogliptin

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 11, 2015-11 ,pp. : 1296-1302

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sevelamer in a diabetologist's perspective: a phosphate‐binding resin with glucose‐lowering potential

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 2, 2015-02 ,pp. : 116-120

John Wiley & Sons Inc

Access to resources Recommend Favorite